Product Recalls: December 18, 2024 – January 15, 2025
Health Letter, February 2025
Note: Never stop taking a drug that appears on the product recall list without first talking to your doctor or pharmacist. Most recalls are limited to a single manufacturer and may not be related to the version of a particular drug you are taking. If a recall does relate to the version of the drug you are taking, you should not stop taking the drug until you discuss an alternative treatment with your doctor or pharmacist.
For Class 1 recalls, there is a potential for serious injury or death.
For Class 2 recalls, there is a potential for serious adverse events but a lower chance of the drug causing serious injury or death than in a Class 1 recall.
CLASS I
clonazepam orally disintegrating tablet; 0.125, 0.25, 1 or 2 mg, 60 tablets per carton, 10 blister cards containing 6 tablets each. Distributed by: PAR Pharmaceutical. Lot #: 550176501 or 550176601, exp. date: 02/28/2027; Lot #: 550174101, exp. date: 01/31/2027; Lot #: 550142801, 550142901, 550143001, 550143101, 550143201, 550143301, 550143401, 550147201 or 550147401, exp. date: 08/31/2026; Lot #: 550145201, exp. date: 08/31/2026; Lot #: 550175901, 550176001 or 550176201, exp. date: 02/28/2027.
CLASS II
chlorpromazine hydrochloride tablets, 10 or 25 mg, 100-count bottle. Manufactured for: Glenmark Pharmaceuticals Inc. Lot#: 17230132, exp. date: 12/2024; Lot #: 17230449, exp. date: 01/2025; Lot #: 17230133, exp. date: 12/31/2024.
clobazam tablets, 10 mg, packaged in 30 tablets per carton (3×10 blister cards each). Manufactured by: Amneal Pharmaceuticals LLC. Lot #: 1019594, exp. date: 12/31/2025.
colchicine capsules, 0.6 mg, 30-count bottles. Manufactured by: Granules Pharmaceuticals Inc. Lot #: GPC240763B, exp. date: 6/17/2026.
duloxetine delayed-release capsules; 20, 30 or 60 mg; 30-, 60-, 90- or 1,000-count bottles, Manufactured by: Towa Pharmaceutical Europe, Rising Pharma, Inc., PD Rx Pharmaceuticals Inc. or Aurobindo Pharma Limited. Lot #: 222205C, exp. date: 11/2025; Lot #: J0786744-061724, exp. date: 06/30/2025; Lot #: B3002625-060524, exp. date: 10/31/2025; Lot #: I24E77 or A24E49, exp. date: 04/30/25; Lot #: J23C50, J23C97, L23B39 or L23E98, exp. date: 01/31/2025; Lot #: 230077C, exp. date: 11/2025; Lot #: DT3023029A, exp. date: 02/28/2025; Lot #: DT3023030A, exp. date: 2/28/2025; Lot #: DT6023061B, exp. date: 01/31/2025; Lot #: DT6022166A, exp. date: 11/30/2024; Lot #: DT6023071A, exp. date: 2/28/2025; Lot #: DT3023051A, exp. date: Apr-25; Lot #: DT3023025A, exp. date: Jan-25; Lot #: DT2023003A, DT2023007A or DT2023008A, exp. date: Jan-25; Lot #: DT6023053A, DT6023061A, DT6023068A or DT6023074A, exp. date: Jan-25; Lot #: DT6023078A or DT6023076A, exp. date: Feb-25; Lot #: DTC24043A or DTC24044A, exp. date: Dec-25; Lot #: DT6023002A, DT6023016A or DT6023036A, exp. date: Dec-24; Lot #: DT6023048A, exp. date: Jan-25.
levothyroxine sodium tablets, 75 mcg (0.075 mg), 1,000 tablets. Manufactured for: Lupin Pharmaceuticals, Inc. Manufactured by: Lupin Limited. Lot #: LA01276, exp. date: 07/2026.
metformin hydrochloride extended-release tablets, 500 mg, 1,000-count bottles. Manufactured by: Granules India Limited. Lot #: 4911311A, exp. date: 11/2025.
nebivolol tablets, 2.5. mg, 30-count bottles. Distributed by: Aurobindo Pharma USA, Inc. Lot #: NB0224001A or NB0224001B, exp. date: 04/2027.
nitrofurantoin capsules, 100 mg, 50 capsules (5 x 10) unit dose per carton. Manufactured for: AvKARE, Inc. Lot #: 47101; exp. date: 02/2026.
olanzapine tablets, 2.5 mg, 30-count bottle. Manufactured by: Macleods Pharmaceuticals, Ltd. Lot #: BOB12318A, exp. date: 07/31/2027.
For more information about the drug recalls listed above, please visit http://www.accessdata.fda.gov/scripts/ires/index.cfm.
CONSUMER PRODUCTS
For a list of recent recalls of consumer products, please visit the Consumer Product Safety Commission website at http://www.cpsc.gov/en/Recalls/.